The rise in gallbladder removal surgeries has prompted medical professionals to investigate potential links to an increase in the use of weight-loss injections. NHS England reported over 80,000 gallbladder procedures in the 2024-25 period, marking a significant rise in cases that has left both patients and healthcare providers seeking answers.
A Surge in Gallbladder Surgeries
Recent statistics reveal that NHS England performed 80,196 gallbladder surgeries in the 2024-25 year, a striking 15% increase from 69,745 in the previous year. This surge marks the highest number of gallbladder operations recorded in the last decade. Specialist surgeons, including Ahmed Ahmed, President of the British Obesity and Metabolic Specialist Society, noted a correlation between these surgeries and the growing number of patients who have utilised weight-loss injections like Mounjaro and Wegovy.
“More and more people are informing me they have been using these injections,” Ahmed stated, underscoring the need for further research to clarify whether the medications directly contribute to gallstone formation or if rapid weight loss associated with these treatments is the root cause. The Medicines and Healthcare products Regulatory Agency (MHRA) has acknowledged gallstones as a potential side effect of these injections, and they are keeping the situation under close surveillance.
Patient Experiences Highlight the Risks
Among those affected is Sue Peacock, a 48-year-old mother from Wirral, who faced life-threatening complications after using Mounjaro. Initially optimistic about the weight-loss injection, Peacock was soon diagnosed with gallstones, leading to severe pancreatitis. “I felt like I was dying… the pain was worse than it had ever been,” she recalled, expressing her fears and the lasting impact on her family. The experience has not only altered her health but has also instilled a constant worry in her children about her well-being.
Although many individuals who have used weight-loss injections report positive outcomes, such as significant weight loss and improved energy levels, the potential risks cannot be overlooked. For instance, Steve O’Farrell, a 67-year-old grandfather from Bristol, experienced remarkable success with Mounjaro, shedding over five stone (34kg). “It’s almost instant,” he remarked, acknowledging that he weighed the risks against the benefits before deciding to proceed with the treatment.
The Medical Community Calls for More Research
As the medical community grapples with these developments, the calls for comprehensive studies grow louder. Surgeon James Hewes, who also specialises in obesity and bariatric surgery, emphasised the need for further investigation into the long-term effects of weight-loss injections. “Anecdotally, we are seeing more patients presenting with gallstones,” he noted, yet he acknowledged the complexities involved in determining the cause.
Experts like Ahmed are advocating for high-quality trials that compare the efficacy and safety of weight-loss injections with traditional bariatric surgery. Such research could provide invaluable insights into the best approaches for managing obesity and protecting patients from potential complications.
Understanding the Risks and Benefits
While the prevalence of gallbladder removals rises, it is important for patients considering weight-loss injections to consult with healthcare professionals about the associated risks. The NHS recognises that gallbladder removal is a common procedure with inherent risks, including infection and blood clots. As both surgeons noted, adopting a gradual approach to weight loss may lessen the chances of developing gallstones.
Manufacturers of these injections, including Eli Lilly and Novo Nordisk, stress that patient safety remains a top priority. They encourage anyone experiencing adverse effects to seek medical advice and report their experiences to the MHRA.
Why it Matters
The increasing number of gallbladder surgeries raises significant questions about the safety of popular weight-loss injections. As more individuals turn to these treatments for obesity management, understanding the potential side effects is crucial. Ongoing research and patient awareness are vital to ensure that the benefits of weight-loss drugs do not come at an unacceptable cost to health. The implications of these findings could reshape clinical practices and patient choices in the management of obesity, underscoring the importance of informed decision-making in healthcare.